Back to search
Alopecia Universalis (AU)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Alopecia Universalis (AU) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Alopecia Universalis (AU) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.
This is an open label study of ATI-502 Topical Solution for the treatment of AA, AU, and AT with the following goals: * To assess the safety, tolerability, and…
The primary objective is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ATI-50002 Topical Solution compared to vehicle in subjects…